uniQure N.V. (NASDAQ: QURE)
$15.9000
-0.0200 ( -1.06% ) 4.7K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$15.9000
Previous close
$15.9200
Volume
4.7K
Market cap
$780.49M
Day range
$15.6200 - $16.4490
52 week range
$3.7300 - $19.1800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 12, 2024 |
4 | Insider transactions | 1 | Dec 10, 2024 |
8-k | 8K-related | 15 | Dec 10, 2024 |
4 | Insider transactions | 1 | Dec 10, 2024 |
8-k | 8K-related | 15 | Nov 21, 2024 |
10-q | Quarterly Reports | 70 | Nov 05, 2024 |
8-k | 8K-related | 15 | Nov 05, 2024 |
8-k | 8K-related | 15 | Oct 15, 2024 |
8-k | 8K-related | 15 | Sep 23, 2024 |
8-k | 8K-related | 15 | Aug 15, 2024 |